샘플 요청 목록

 카트 문의
시장보고서
상품코드
1792898

세계의 예르시니아 진단 시장

Yersinia Diagnostics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 480 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

예르시니아 진단 세계 시장은 2030년까지 3억 8,370만 달러에 달할 전망

2024년에 2억 9,600만 달러로 추정되는 예르시니아 진단 세계 시장은 2030년에는 3억 8,370만 달러에 달하고, 분석 기간인 2024-2030년 CAGR은 4.4%로 성장할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 예르시니아 진단 기기는 CAGR 3.7%를 기록하며 분석 기간 종료까지 2억 5,780만 달러에 달할 것으로 예측됩니다. 예르시니아 진단 키트 및 시약 부문의 성장률은 분석 기간 동안 CAGR 6.1%로 추정됩니다.

미국 시장은 추정 8,060만 달러, 중국은 CAGR 6.9%로 성장 예측

미국의 예르시니아 진단 시장은 2024년에 8,060만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 7,430만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 6.9%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 2.1%와 4.4%로 예측됩니다. 유럽에서는 독일이 CAGR 2.8%로 성장할 것으로 예측됩니다.

세계의 예르시니아 진단 시장 - 주요 동향과 촉진요인 정리

식중독에 대한 인식이 높아지면서 예르시니아 진단 수요 증가?

공중 보건 당국, 임상의, 식품 안전 규제 당국이 오염된 음식과 물에서 발생하는 세균 감염을 막기 위한 노력을 강화함에 따라 세계 예르시니아 진단 시장도 꾸준히 성장하고 있습니다. 예르시니아, 특히 예르시니아 엔테로콜리티카와 예르시니아 슈도츠베르그 클로시스는 특히 소아 및 면역력이 약한 사람에게서 위장 질환의 심각한 원인으로 인식되고 있습니다. 이 박테리아는 종종 가열이 불충분한 돼지고기, 저온 살균되지 않은 우유, 처리되지 않은 물과 관련이 있으며, 감시 개선 및 조기 발견의 중요한 목표가 되고 있습니다. 식중독이 전 세계적으로 의료비 상승과 생산성 저하에 기여하고 있는 만큼, 예르시니아 감염을 조기에 정확하게 진단하는 것이 공중보건의 최우선 과제가 되고 있습니다. 인수공통전염병과 전염병 발생 가능성에 대한 인식이 높아지면서 병원, 검사기관, 식품검사기관이 보다 강력한 진단 도구에 투자하도록 유도하고 있습니다. 국가 보건 시스템이 질병 추적 능력을 강화함에 따라 소화기 감염 진단 패널에 예르시니아를 포함하는 것이 일반화되고 있습니다. 일상적인 진단은 임상 검사실뿐만 아니라 국경검사소, 동물병원, 식품가공시설에서도 중요하게 다루어지고 있습니다. 이러한 노력은 예르시니아 관련 질병을 보다 효과적으로 예방하고 관리하기 위한 노력의 증가를 반영하며, 진단학은 현대 감염병 대응 전략의 최전방 방어 수단으로 자리매김하고 있습니다.

분자 검사 및 면역측정 검사의 기술 발전은 어떻게 검출 능력을 향상시키고 있는가?

최근 진단 기술의 발전으로 예르시니아 검출법의 속도, 민감도, 특이성이 크게 향상되었습니다. 전통적인 배양 기반 기술은 현재도 널리 사용되고 있지만, 보다 빠르고 정확한 결과를 제공하는 분자진단 및 면역 측정법으로 보완되고 있습니다. 실시간 PCR 및 멀티플렉스 PCR을 포함한 중합효소 연쇄 반응(PCR) 기술은 임상 샘플이나 환경 샘플에서 직접, 종종 몇 시간 내에 예르시니아 DNA를 검출할 수 있습니다. 이러한 검사는 장시간 배양의 필요성을 줄이고 임상의가 더 빨리 표적 치료를 시작할 수 있도록 도와줍니다. 효소 결합 면역 흡착 분석법(ELISA)과 측면 흐름 분석법도 엘시니아균에 특이적인 항원 및 항체를 확인하기 위해 개발되었으며, 현장 진단 및 대규모 스크리닝 프로그램 모두에 유용하게 사용될 수 있습니다. 바이오센서 기술, 미세유체 장치, 랩온칩 플랫폼의 혁신은 자원이 제한된 환경에서도 도입할 수 있는 휴대가 가능하고 사용자 친화적인 진단 도구에 기여하고 있습니다. 자동화 플랫폼은 중앙 집중식 실험실의 처리량을 더욱 향상시키고, 인적 오류를 줄이며, 표준화를 개선합니다. 진단 기업들이 여러 병원균을 동시에 검출할 수 있는 멀티플렉스 시스템에 집중함에 따라, 엘시니아균은 종합적인 소화관 패널에 포함되는 경우가 많아지고 있으며, 그 가시성과 진단 수율이 향상되고 있습니다. 이러한 기술 혁신은 검사 선택의 폭을 넓힐 뿐만 아니라, 보다 광범위한 감시와 발병에 대한 신속한 공중보건 대응을 촉진하고 있습니다.

식품 안전 규제와 감시 관행의 변화가 시장 역학에 영향을 미치고 있는가?

식품 안전 규제와 공중 보건 감시의 세계적 변화는 정확하고 시기적절한 예르시니아 진단 약품에 대한 수요를 촉진하는 데 중요한 역할을 하고 있습니다. 식품의 국제 무역이 확대됨에 따라 세균성 병원체가 국경을 넘어 전파될 가능성이 높아지면서 각국은 더욱 엄격한 수출입 검사 요건을 시행하고 있습니다. 유럽식품안전청(EFSA), 미국 식품의약국(FDA), 세계보건기구(WHO) 등의 규제 기관은 일상적인 식품 안전 감사의 일환으로 엘시니아균 검출을 포함한 견고한 미생물 모니터링 시스템의 중요성을 강조하고 있습니다. 식품 가공 산업은 위해요소 분석 및 중요관리점(HACCP) 프로토콜을 채택하고 있으며, 규정 준수를 검증하고 소비자 보호를 보장하기 위해 신뢰할 수 있는 진단 방법이 필요합니다. 전국적인 질병 감시 시스템이 강화되어 발병을 실시간으로 감지하고 보고할 수 있도록 강화되고 있으며, 예르시니아는 보고 의무가 있는 질병으로 등재되고 있습니다. 농장에서 식탁까지 추적 가능성에 대한 요구는 농업, 동물 위생, 식품 생산 부문에 진단의 기회를 창출하고 있습니다. 또한, 수자원, 축산 환경, 식품 생산 라인의 세균 오염 물질 파악을 위한 환경 모니터링으로 예르시니아 진단의 적용 범위는 병원 외에도 확대되고 있습니다. 이러한 규제적 압력과 모니터링 이니셔티브는 진단 도구와 인프라에 대한 지속적인 투자를 위한 강력한 기반을 구축하여 세균 감염에 대한 공중보건 대응이 예방적이고 효과적으로 유지될 수 있도록 보장합니다.

예르시니아 진단 시장의 장기적 성장을 뒷받침하는 핵심 동인은 무엇인가?

예르시니아 진단 시장의 성장은 헬스케어 인식, 기술 혁신, 공공안전 우선순위, 세계 보건 이니셔티브와 관련된 여러 가지 수렴 요인에 의해 주도되고 있습니다. 주요 촉진요인은 특히 인구 밀집 지역과 자원이 부족한 지역에서 오염된 음식과 물과 관련된 위장병 발생률의 증가입니다. 식중독에 대한 소비자의 인식이 높아지면서 조기 건강관리에 대한 관심이 높아졌고, 이에 따라 접근성이 높고 정확한 진단약에 대한 수요가 증가하고 있습니다. 의료진이 증상의 근본 원인을 신속하게 파악하고 불필요한 항생제 사용을 최소화하기 위해 임상 현장에서 보다 종합적인 진단 패널이 요구되고 있는 것도 중요한 요소입니다. 인공지능과 데이터 분석의 통합을 포함한 진단 플랫폼의 발전은 보다 빠른 해석과 진단 정확도 향상을 가능하게 하고 있습니다. 연구기관, 공중보건기관, 생명공학 기업 간의 전략적 파트너십을 통해 새로운 분석법 개발을 가속화하고 시장 개척을 확대하고 있습니다. 또한, 전 세계가 전염병 대비 및 항균제 내성(AMR) 감시를 강화하려는 노력으로 인해 광범위한 감염 모니터링 전략의 일환으로 예르시니아를 포함한 병원체 탐지 시스템에 대한 투자가 장려되고 있습니다. 교육 캠페인과 훈련 프로그램을 통해 검사 기술자와 의료진이 예르시니아 감염을 효과적으로 인식하고 검사할 수 있는 능력을 향상시키고 있습니다. 이러한 요인들이 결합되어 시장 환경은 견고하고 확장 가능하며, 기술 혁신, 정책과의 일관성, 공중 보건의 우선 순위가 결합되어 지속적인 성장과 관련성을 가져왔습니다.

부문

제품(예르시니아 진단 기기, 예르시니아 진단 키트 및 시약), 진단 검사(변 배양 검사, 영상 검사, 혈청학적 검사, 대장내시경 검사, 기타 진단 검사), 기술(면역측정법 기술, DNA 프로브 기술, 중합효소 연쇄 반응 기술, 유세포 분석 기술, 크로마토그래피 기술, 기타 기술), 최종사용자(병원 최종사용자, 공중위생 연구소 최종사용자, 상업 연구소 최종사용자, 기타 최종사용자)

조사 대상 기업 사례

  • Abbott Laboratories
  • Abingdon Health
  • Affymetrix(now part of Thermo Fisher)
  • AID Autoimmun Diagnostika
  • BioFire Diagnostics(now part of bioMerieux)
  • BioMerieux
  • BioPerfectus Technologies
  • Bio-Rad Laboratories
  • BioThreat Alert(R)(Tetracore)
  • Certest Biotec
  • Creative Dx(Gentaur distributor)
  • Danaher Corporation
  • DiaSorin
  • DNA-Technology
  • EIA/Blot Yersinia kits(TestLine)
  • Gold Standard Diagnostics
  • Hardy Diagnostics
  • Hologic(formerly Gen-Probe)
  • Medcaptain Medical Tech
  • R-Biopharm AG

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.25

Global Yersinia Diagnostics Market to Reach US$383.7 Million by 2030

The global market for Yersinia Diagnostics estimated at US$296.0 Million in the year 2024, is expected to reach US$383.7 Million by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Yersinia Diagnostic Instruments, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$257.8 Million by the end of the analysis period. Growth in the Yersinia Diagnostic Kits & Reagents segment is estimated at 6.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$80.6 Million While China is Forecast to Grow at 6.9% CAGR

The Yersinia Diagnostics market in the U.S. is estimated at US$80.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$74.3 Million by the year 2030 trailing a CAGR of 6.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.1% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Yersinia Diagnostics Market - Key Trends & Drivers Summarized

Is Growing Awareness of Foodborne Diseases Fueling the Demand for Yersinia Diagnostics?

The global Yersinia diagnostics market is expanding steadily as public health authorities, clinicians, and food safety regulators intensify their efforts to combat bacterial infections that arise from contaminated food and water. Yersinia, particularly Yersinia enterocolitica and Yersinia pseudotuberculosis, is increasingly recognized as a significant cause of gastrointestinal illness, particularly in children and immunocompromised individuals. The bacterium is often associated with undercooked pork, unpasteurized milk, and untreated water, making it a key target for improved surveillance and early detection. With foodborne diseases contributing to rising healthcare costs and productivity losses globally, early and accurate diagnosis of Yersinia infections is becoming a public health priority. Increased awareness about zoonotic transmission and potential outbreaks is also prompting hospitals, laboratories, and food testing agencies to invest in more robust diagnostic tools. As national health systems strengthen their disease tracking capabilities, the inclusion of Yersinia in diagnostic panels for gastrointestinal infections is becoming more commonplace. Routine diagnostics are being emphasized not only in clinical laboratories but also in border inspection posts, veterinary centers, and food processing facilities. These efforts reflect a growing commitment to preventing and managing Yersinia-related illnesses more effectively, positioning diagnostics as a frontline defense in modern infectious disease control strategies.

How Are Technological Advances in Molecular and Immunoassay Testing Enhancing Detection Capabilities?

Recent advances in diagnostic technology are significantly improving the speed, sensitivity, and specificity of Yersinia detection methods. Traditional culture-based techniques, while still widely used, are increasingly being supplemented by molecular diagnostics and immunoassays that offer quicker and more precise results. Polymerase chain reaction (PCR) techniques, including real-time and multiplex PCR, allow for the detection of Yersinia DNA directly from clinical or environmental samples, often within a matter of hours. These tests reduce the need for extended incubation periods and help clinicians initiate targeted treatments much sooner. Enzyme-linked immunosorbent assays (ELISAs) and lateral flow assays are also being developed to identify Yersinia-specific antigens or antibodies, making them valuable for both point-of-care diagnostics and large-scale screening programs. Innovations in biosensor technology, microfluidic devices, and lab-on-a-chip platforms are contributing to portable and user-friendly diagnostic tools that can be deployed in resource-limited settings. Automated platforms are further enhancing throughput in centralized laboratories, reducing human error and improving standardization. As diagnostic companies focus on multiplex systems that can simultaneously detect multiple pathogens, Yersinia is increasingly included in comprehensive gastrointestinal panels, increasing its visibility and diagnostic yield. These technological innovations are not only expanding the range of testing options available but are also facilitating broader surveillance and quicker public health responses to outbreaks.

Are Shifts in Food Safety Regulations and Surveillance Practices Impacting Market Dynamics?

Global shifts in food safety regulations and public health surveillance are playing a critical role in driving demand for accurate and timely Yersinia diagnostics. As international trade in food products expands, so does the potential for cross-border transmission of bacterial pathogens, prompting countries to implement stricter import and export testing requirements. Regulatory agencies such as the European Food Safety Authority (EFSA), the U.S. Food and Drug Administration (FDA), and the World Health Organization (WHO) are emphasizing the importance of robust microbiological monitoring systems that include Yersinia detection as part of routine food safety audits. Food processing industries are adopting hazard analysis and critical control point (HACCP) protocols that require reliable diagnostic methods to verify compliance and ensure consumer protection. National disease surveillance systems are being strengthened to detect and report outbreaks in real time, with Yersinia increasingly listed as a reportable disease. The demand for traceability from farm to fork is creating opportunities for diagnostics in agriculture, animal health, and food production sectors. Additionally, environmental monitoring initiatives aimed at identifying bacterial contaminants in water sources, livestock environments, and food production lines are expanding the application of Yersinia diagnostics beyond hospitals. These regulatory pressures and monitoring initiatives are creating a strong foundation for sustained investment in diagnostic tools and infrastructure, ensuring that public health responses to bacterial infections remain proactive and effective.

What Core Drivers Are Supporting Long-Term Growth in the Yersinia Diagnostics Market?

The growth in the Yersinia diagnostics market is driven by multiple converging factors related to healthcare awareness, technological innovation, public safety priorities, and global health initiatives. A primary driver is the increasing incidence of gastrointestinal infections linked to contaminated food and water, particularly in densely populated and low-resource regions. Rising consumer awareness around foodborne illnesses is prompting earlier healthcare engagement, which in turn boosts demand for accessible and accurate diagnostics. Another important factor is the push for more comprehensive diagnostic panels in clinical settings, as healthcare providers seek to identify the root cause of symptoms quickly and minimize unnecessary use of antibiotics. Advances in diagnostic platforms, including the integration of artificial intelligence and data analytics, are also enabling faster interpretation and improved diagnostic accuracy. Strategic partnerships between research institutions, public health agencies, and biotechnology firms are accelerating the development of novel assays and expanding market access. Furthermore, global efforts to strengthen pandemic preparedness and antimicrobial resistance (AMR) surveillance are encouraging investments in pathogen detection systems that include Yersinia as part of a broader infectious disease monitoring strategy. Educational campaigns and training programs are increasing the capacity of laboratory technicians and healthcare workers to recognize and test for Yersinia infections effectively. Together, these factors are establishing a robust and scalable market landscape for Yersinia diagnostics, where innovation, policy alignment, and public health priorities collectively drive continued growth and relevance.

SCOPE OF STUDY:

The report analyzes the Yersinia Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Yersinia Diagnostic Instruments, Yersinia Diagnostic Kits & Reagents); Diagnostic Test (Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test, Other Diagnostic Tests); Technology (Immunoassay Technology, DNA Probes Technology, Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies); End-Use (Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Abbott Laboratories
  • Abingdon Health
  • Affymetrix (now part of Thermo Fisher)
  • AID Autoimmun Diagnostika
  • BioFire Diagnostics (now part of bioMerieux)
  • BioMerieux
  • BioPerfectus Technologies
  • Bio-Rad Laboratories
  • BioThreat Alert(R) (Tetracore)
  • Certest Biotec
  • Creative Dx (Gentaur distributor)
  • Danaher Corporation
  • DiaSorin
  • DNA-Technology
  • EIA/Blot Yersinia kits (TestLine)
  • Gold Standard Diagnostics
  • Hardy Diagnostics
  • Hologic (formerly Gen-Probe)
  • Medcaptain Medical Tech
  • R-Biopharm AG

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Yersinia Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Foodborne Illnesses Propels Demand for Rapid Yersinia Diagnostic Solutions
    • Global Surveillance Programs for Zoonotic Diseases Strengthen the Business Case for Yersinia Testing
    • Increased Emphasis on Food Safety and Hygiene Standards Expands the Addressable Market for Yersinia Detection
    • Advancements in PCR and Molecular Diagnostics Drive Adoption of High-Sensitivity Detection Platforms
    • Biothreat Preparedness and Biosecurity Measures Throw the Spotlight on Yersinia pestis Surveillance
    • Growing Awareness Among Clinicians Accelerates Early Diagnosis and Appropriate Treatment of Yersiniosis
    • Integration of Point-of-Care Technologies Spurs Demand in Remote and Resource-Limited Settings
    • Outbreak Management Protocols Create Opportunities for Real-Time, Multiplex Diagnostic Systems
    • Expansion of Veterinary Diagnostics Strengthens Demand for Yersinia Testing in Animal Reservoirs
    • Evolving Genomic Sequencing Capabilities Drive Innovation in Strain Differentiation and Epidemiological Tracking
    • Decentralization of Diagnostic Services Propels Adoption of Compact and Automated Testing Devices
    • Growing Global Burden of Gastrointestinal Infections Reinforces the Need for Scalable Yersinia Diagnostic Platforms
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Yersinia Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Yersinia Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Yersinia Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Yersinia Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Yersinia Diagnostic Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Yersinia Diagnostic Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Yersinia Diagnostic Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Yersinia Diagnostic Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Yersinia Diagnostic Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Yersinia Diagnostic Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Polymerase Chain Reaction Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Polymerase Chain Reaction Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Flow Cytometry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Flow Cytometry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Flow Cytometry Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Chromatography Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Chromatography Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Chromatography Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Immunoassay Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Immunoassay Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Immunoassay Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for DNA Probes Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for DNA Probes Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for DNA Probes Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Public Health Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Public Health Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Public Health Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Commercial Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Commercial Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Commercial Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Stool Culture Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Stool Culture Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: World 16-Year Perspective for Stool Culture Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Imaging Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Imaging Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: World 16-Year Perspective for Imaging Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Serological Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Serological Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: World 16-Year Perspective for Serological Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Colonoscopy Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Colonoscopy Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: World 16-Year Perspective for Colonoscopy Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 53: World Recent Past, Current & Future Analysis for Other Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: World Historic Review for Other Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: World 16-Year Perspective for Other Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Yersinia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 56: USA Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: USA 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 59: USA Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: USA Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: USA 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 62: USA Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: USA Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: USA 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 65: USA Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: USA Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: USA 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 68: Canada Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Canada Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Canada 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 71: Canada Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Canada 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 74: Canada Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Canada Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Canada 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 77: Canada Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Canada Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Canada 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • JAPAN
    • Yersinia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 80: Japan Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Japan Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Japan 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 83: Japan Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Japan Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Japan 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 86: Japan Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Japan Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Japan 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 89: Japan Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Japan Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Japan 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • CHINA
    • Yersinia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 92: China Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: China Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: China 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 95: China Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: China Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: China 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 98: China Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: China Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: China 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 101: China Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: China Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: China 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • EUROPE
    • Yersinia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Yersinia Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Yersinia Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Europe 16-Year Perspective for Yersinia Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 107: Europe Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Europe Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Europe 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 110: Europe Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Europe Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Europe 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 113: Europe Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Europe Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Europe 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 116: Europe Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Europe Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: Europe 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • FRANCE
    • Yersinia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 119: France Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: France Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: France 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 122: France Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: France Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: France 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 125: France Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: France Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: France 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 128: France Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: France Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: France 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • GERMANY
    • Yersinia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 131: Germany Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Germany Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Germany 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 134: Germany Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Germany Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Germany 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 137: Germany Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Germany Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Germany 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 140: Germany Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Germany Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Germany 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 143: Italy Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Italy Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Italy 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 146: Italy Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Italy Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Italy 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 149: Italy Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Italy Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Italy 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 152: Italy Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Italy Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Italy 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Yersinia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 155: UK Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: UK Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: UK 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 158: UK Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: UK Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: UK 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 161: UK Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: UK Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: UK 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 164: UK Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: UK Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: UK 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 167: Spain Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Spain Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Spain 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 170: Spain Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Spain Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Spain 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 173: Spain Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Spain Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Spain 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 176: Spain Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Spain Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Spain 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 179: Russia Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Russia Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Russia 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 182: Russia Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Russia Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Russia 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 185: Russia Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Russia Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Russia 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 188: Russia Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Russia Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Russia 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Europe Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Rest of Europe 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Europe Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Europe 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Europe Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Europe 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Europe Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Europe 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Yersinia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Yersinia Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 204: Asia-Pacific Historic Review for Yersinia Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Asia-Pacific 16-Year Perspective for Yersinia Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Asia-Pacific Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Asia-Pacific 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Asia-Pacific Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Asia-Pacific 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Asia-Pacific Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: Asia-Pacific 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Asia-Pacific Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Asia-Pacific 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Yersinia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 218: Australia Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Australia Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 220: Australia 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 221: Australia Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Australia Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 223: Australia 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 224: Australia Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Australia Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 226: Australia 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 227: Australia Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Australia Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 229: Australia 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • INDIA
    • Yersinia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 230: India Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: India Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 232: India 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 233: India Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: India Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 235: India 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 236: India Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: India Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 238: India 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 239: India Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: India Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 241: India 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 242: South Korea Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: South Korea Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 244: South Korea 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 245: South Korea Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: South Korea Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 247: South Korea 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 248: South Korea Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: South Korea Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 250: South Korea 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 251: South Korea Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: South Korea Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 253: South Korea 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Rest of Asia-Pacific Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 256: Rest of Asia-Pacific 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Rest of Asia-Pacific Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 259: Rest of Asia-Pacific 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 260: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Rest of Asia-Pacific Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 262: Rest of Asia-Pacific 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 263: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Rest of Asia-Pacific Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 265: Rest of Asia-Pacific 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Yersinia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 266: Latin America Recent Past, Current & Future Analysis for Yersinia Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 267: Latin America Historic Review for Yersinia Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 268: Latin America 16-Year Perspective for Yersinia Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 269: Latin America Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Latin America Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 271: Latin America 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 272: Latin America Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Latin America Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 274: Latin America 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 275: Latin America Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Latin America Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 277: Latin America 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 278: Latin America Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Latin America Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 280: Latin America 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 281: Argentina Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Argentina Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 283: Argentina 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 284: Argentina Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Argentina Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 286: Argentina 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 287: Argentina Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Argentina Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 289: Argentina 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 290: Argentina Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Argentina Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 292: Argentina 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 293: Brazil Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Brazil Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 295: Brazil 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 296: Brazil Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Brazil Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 298: Brazil 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 299: Brazil Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Brazil Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 301: Brazil 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 302: Brazil Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Brazil Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 304: Brazil 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 305: Mexico Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Mexico Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 307: Mexico 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 308: Mexico Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Mexico Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 310: Mexico 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 311: Mexico Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Mexico Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 313: Mexico 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 314: Mexico Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Mexico Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 316: Mexico 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Rest of Latin America Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 319: Rest of Latin America 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Rest of Latin America Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 322: Rest of Latin America 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 323: Rest of Latin America Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Rest of Latin America Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 325: Rest of Latin America 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 326: Rest of Latin America Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Rest of Latin America Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 328: Rest of Latin America 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Yersinia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 329: Middle East Recent Past, Current & Future Analysis for Yersinia Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 330: Middle East Historic Review for Yersinia Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 331: Middle East 16-Year Perspective for Yersinia Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 332: Middle East Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Middle East Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 334: Middle East 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 335: Middle East Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Middle East Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 337: Middle East 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 338: Middle East Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Middle East Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 340: Middle East 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 341: Middle East Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Middle East Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 343: Middle East 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 344: Iran Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Iran Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 346: Iran 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 347: Iran Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Iran Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 349: Iran 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 350: Iran Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Iran Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 352: Iran 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 353: Iran Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Iran Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 355: Iran 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 356: Israel Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Israel Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 358: Israel 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 359: Israel Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Israel Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 361: Israel 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 362: Israel Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Israel Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 364: Israel 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 365: Israel Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Israel Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 367: Israel 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 369: Saudi Arabia Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 370: Saudi Arabia 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Saudi Arabia Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 373: Saudi Arabia 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 374: Saudi Arabia Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Saudi Arabia Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 376: Saudi Arabia 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 377: Saudi Arabia Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Saudi Arabia Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 379: Saudi Arabia 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 380: UAE Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 381: UAE Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 382: UAE 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 383: UAE Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 384: UAE Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 385: UAE 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 386: UAE Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 387: UAE Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 388: UAE 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 389: UAE Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 390: UAE Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 391: UAE 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Rest of Middle East Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 394: Rest of Middle East 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Rest of Middle East Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 397: Rest of Middle East 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 398: Rest of Middle East Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Rest of Middle East Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 400: Rest of Middle East 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 401: Rest of Middle East Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 402: Rest of Middle East Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 403: Rest of Middle East 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
  • AFRICA
    • Yersinia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 404: Africa Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 405: Africa Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 406: Africa 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
    • TABLE 407: Africa Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 408: Africa Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 409: Africa 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
    • TABLE 410: Africa Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 411: Africa Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 412: Africa 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 413: Africa Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 414: Africa Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 415: Africa 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제